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Abstract 
 
Quality audits and intercomparisons are greatly important in ensuring control of processes in 
any system of endeavour. Present interest is in control of dosimetry in teletherapy, there 
being a need to assess the extent to which there is consistent radiation dose delivery to the 
patient. In this study we review significant factors that impact upon radiotherapy dosimetry, 
focusing upon the example situation of radiotherapy delivery in Malaysia, examining existing 
literatures in support of such efforts. A number of recommendations are made to provide for 
increased quality assurance and control. In addition to this study, the first level of 
intercomparison audit i.e. measuring beam output under reference conditions at eight selected 
Malaysian radiotherapy centres is checked; use being made of 9 μm core diameter Ge-doped 
silica fibres (Ge-9μm). The results of Malaysian Secondary Standard Dosimetry Laboratory 
(SSDL) participation in the IAEA/WHO TLD postal dose audit services during the period 
between 2011 and 2015 will also been discussed. In conclusion, following review of the 
development of dosimetry audits and the conduct of one such exercise in Malaysia, it is 
apparent that regular periodic radiotherapy audits and intercomparison programmes should be 
strongly supported and implemented worldwide. The programmes to-date demonstrates these 
to be a good indicator of errors and of consistency between centres. A total of eight beams 
have been checked in eight Malaysian radiotherapy centres. One out of the eight beams 
checked produced an unacceptable deviation; this was found to be due to unfamiliarity with 
the irradiation procedures. Prior to a repeat measurement, the mean ratio of measured to 
quoted dose was found to be 0.99 with standard deviation of 3%. Subsequent to the repeat 
measurement, the mean distribution was 1.00, and the standard deviation was 1.3%. 
 
Keywords: Quality audit, intercomparison, radiotherapy, Ge-doped, Malaysia 
1. Introduction 
The medical use of radiation and the supporting dosimetry are well understood processes, 
controlled in accord with established international practices and tolerances. Protocols 
supporting these continue to evolve in line with the notion of continuing quality 
improvement. Present interest concerns therapeutic applications and in particular, the 
accuracy and precision of delivery of the elevated doses that support curative and palliative 
*Manuscript
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scenarios, towards promoting quality of life of the sufferer. Discrepancies from prescribed 
doses have potential subtle, severe or even lethal consequences, depending on the magnitude 
of discrepancies. In regard to manifest discrepancies, one draws attention to a number of 
well-publicised radiotherapy incidents, catalogued and analysed by the International Atomic 
Energy Agency (IAEA) [1]. Not least among the considerable efforts that have been devoted 
in national and international contexts towards minimising errors and uncertainties in dose 
delivery is the dosimetric audit and intercomparison exercise. As part of the quality assurance 
(QA) process, to ensure continuing improvement in the quality in radiation treatment [2, 3], 
the dosimetric audit has an important role in ensuring optimised clinical outcomes. In this 
respect, in order to achieve consistency and accuracy in delivery absorbed dose to a target 
volume in radiotherapy dosimetry, the ICRU (International Commission on Radiation Units 
and Measurements) issued Report 24, calling for dose delivery to within at least ± 5% of the 
prescribed dose [4]. Others more recent reviews have recommended stricter limits on dose 
delivery, as for instance, ± 3.5% [5] and ± 3% [6]. Here, the dosimetry audit and 
intercomparison exercises have been introduced as part of the effort towards conforming to 
such recommendations, seeking to detect errors, inexact implementation or misinterpretation 
of recommendations, equipment issues or mistakes [7].  
2.  Legislative framework in Malaysia 
The Atomic Energy Licensing Act 1984 (Act 304) is the primary instrument in controlling 
the use of ionising radiation in industrial and medical sectors in Malaysia. The Act is 
supported by its subsidiary regulations which provide safety standards for radiation practices, 
guidelines for licensing and enforcement activities and transport requirements for radioactive 
materials and waste. Some of these regulations are currently under review, with new 
regulations yet to be approved. The Act replaced the previous Radioactive Substances Act 
1968, in April 1984, due to the rapid growth of atomic energy activities in Malaysia. The Act 
has a clause for the formation of the Atomic Energy Licensing Board (AELB) to operate as 
the highest authority in order to enforce the requirements act and its subsidiary regulations 
[8]. It also has a clause identifying the Director General of Health Malaysia as the authority 
enforcing requirements of the Act and its subsidiary regulations for medical activities. In 
addition to the Act and its regulations, the legal framework is also supported by other legally 
binding circulars, standards, and guidelines together with non-legally binding local rules and 
instruction manuals (Figure 1). 
In order to ensure that the existing Act and regulations continue to be appropriate for current 
technology without neglect of the social and economic factors in Malaysia, the AELB with 
the help of the International Atomic Energy Agency (IAEA) has initiated a process of 
revision. Progress of the revision exercise process has been slow for a number of reasons, the 
current status of the revision and the recommendations of the IAEA being discussed by Mohd 
Yusof [8]. In parallel, with the help of several international bodies, the Ministry of Health 
Malaysia (MOH) is developing more specific and comprehensive regulations concerning 
control of the use of ionising radiation in the medical sector.  
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3. Development of dosimetry audits in Malaysia 
The Atomic Energy Licensing Board (AELB) and the Ministry of Health Malaysia (MOH), 
the principal authorities for ensuring radiation safety within the country, have played an 
important role in dosimetry audit development in Malaysia. Together with other agencies 
such as the Malaysian Nuclear Agency (MNA) [9], the Malaysian Association of Medical 
Physics (MAMP) [10], the Associate of Private Hospitals (APHM) [11] and the Malaysian 
Radiation Protection Association (MARPA) [12], national research, and development (R&D) 
efforts are now well established. As a member state, Malaysia also receives assistance from 
the IAEA in the form of expert visits and financial support [13]. 
The Malaysian Secondary Standard Dosimetry Laboratory (SSDL), established within the 
MNA is recognized by the Malaysian accreditation body as a national calibration laboratory 
for radiation protection and radiotherapy purposes. This laboratory is for instance responsible 
for providing personal dosimeters to all users in Malaysia, having now done so for in excess 
of 18 years [8]; it also ensures that all instruments used in radiation at therapy, protection and 
environmental levels are calibrates. For present interest this includes radiation survey meters 
and therapy dosimeters (ion chambers), calibrated following the relevant IAEA Codes of 
Practices, as provided for by the IAEA as a Primary Standard Dosimetry Laboratory 
(PSDL)[14]. 
Atomic Energy Licensing Act 1984 (Act 304)  
(Regulatory Authority) 
INDUSTRIAL 
Ministry of Science, Technology 
 and Innovation (MOSTI) 
 
 
 
Executive Secretary to the Board 
Secretariat: 
AELB (Dept) 
MEDICAL 
 
Ministry of Health Malaysia 
 
Director General of Health 
Secretariat: 
Radiation Health & Safety Section, 
Engineering Services Division 
Figure 1: Organisational arrangements for control of sources of ionising 
radiations in Malaysia 
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In medical radiation practices, currently, in Malaysia there are 54 linear accelerators, 2 
cobalt-60 teletherapy machines, 15 brachytherapy units, 11 simulators and 4 computerised 
tomography units, operating in 27 radiotherapy and oncology centres [15,16]. In order to 
ensure these facilities produce consistent and accurate absorbed dose delivery, audits and 
intercomparison exercises are being carried out, predominantly by the MNA SSDL, with 
cooperation from the Ministry of Health Malaysia (MOH).  
4. Review of participations of audit and intercomparison programmes 
Most prominent among the audit and intercomparison programmes have been those for 
megavoltage photon beams, being a programme organized by the IAEA/WHO [11] in 
collaboration with the SSDL. Thirty seven such exercises have been carried out over the 
period 1985-2008. Other programmes in which the SSDL have similar involvement are: 
kilovoltage photon beams [17] (carried out from 1993-1995), electron beams [18], dose 
equivalent HP (10) in mixed n- fields [8] and deep dose (HP (10)) and skin dose (HP (0.07) 
assessments. 
SSDL also has participated in the two keys comparison project of: (i) measurement of air 
kerma for medium-energy x-rays (100 kV to 250 kV) between 2000 and 2003 [19]; and (ii) 
comparison of absorbed dose to water for 
60
Co between 2009 and 2010 [20] performed by 
APMP (Asia Pacific Metrology Programme) Dosimetry Working Group. From a bilateral 
comparison with BIPM, the measured value of the Nuclear Malaysia and BIPM calibration 
coefficient agreed within 1.2% at each of the four x-ray beam qualities and 0.22% for 
absorbed dose to water using 
60
Co. 
Other than IAEA involved evaluations, there has also been an intercomparison study by 
Rassiah et al [21], organized as a collaboration between the University of Malaya Medical 
Centre (UMMC) and the University of Wisconsin, Radiation Calibration Laboratory 
(UWRCL). In general, three types of dosimeters have been used in these intercomparisons: 
ionisation chambers [22], Lithium fluoride thermo luminescence dosimeters (TLD’s) [15] 
and alanine [8]. To-date, 
60
Co, 6MV, 10MV, 15MV and 18MV energies have been checked 
by the IAEA for beam calibrations [15].  
According to S.B.Samat et al [15], the result for TLDs and ion chambers comparisons during 
the years of 1985 to 2008 (given as percentage deviations between SSDL Malaysian stated 
doses and IAEA mean dose), showing that the discrepancies are well within the IAEA limit 
of ± 3.5%. Conversely, results of the TLD studies carried out by Rassiah et al. [19] and 
supported by Norhayati et al. [23] showed there to be a few radiotherapy centres yielding 
deviations of greater than ± 5%, being traced to errors in irradiation set-up such as incorrect 
field size or Source to Surface Distance (SSD), mistake in absorbed dose calculation and 
sometimes to lack of physics support at 
60
 Co beam facilities.  
In 2000,  SSDL also use alanine dosimeters for IAEA intercomparison, to check on its 
gamma calibration facilities and the deviations were found to be within the acceptable limit 
set by IAEA i.e. ± 5% [8]. 
5. Benefits of Malaysian national dosimetry audits and problems reported 
Currently, there are no known published reports concerning radiotherapy incidents in 
developing countries in Asia or Africa [24]. In addition, the paucity of data regarding quality 
control of delivery of dose in such regions leads to no real understanding of the extent to 
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which quality is maintained, although it is clear that this is highly variable. The only 
published studies have concerned evaluation of dosimetry practices in a number of 
developing countries, focusing on measurements carried out by Izweska et al [25, 26]. In 
regard to Malaysia, the intercomparison programme has increased confidence in the accuracy 
and consistency of dose delivery in radiation therapy [21, 27]. Furthermore, an external audit 
of an oncology practices enables identification of ‘areas of need’ in terms of gaps in 
knowledge and skills of the staff involved [28].  
Thus said, there remains a number unsolved problems in seeking to implement a 
comprehensive audit intercomparison programme in Malaysia, including a lack of 
experienced medical physicists [21] and high workloads for the radiation oncology staff [17, 
29].  
6. Recommendations 
A number of recommendations have been offered in addressing the problems stated above. 
These are:  
(i) While Samat et al (2009) [15] noted results from a Malaysian postal audit at radiotherapy 
level 1 (postal audits for photon beams in reference condition), it would seem necessary to 
extend future auditing activities at level 2 by using more complex methodologies, as 
proposed by  the IAEA (e.g. non-reference condition) [16, 30]; 
(ii) Device checks should be made towards the end of the dosimetry chain [31] (where the 
doses within a standard phantom for a planned treatment are measured, covering checks of 
basic dosimetry, patient data acquisition, treatment planning and delivery); 
(iii) Strengthening of radiotherapy infrastructures to improve the audit outcomes to make this 
comparable with that of developed countries and to enhance the training of medical radiation 
physics staff and suitable dosimetry facilities [28,32]; 
(v) A good networking between the Malaysia government, private sectors, and non-
government organisations are needed in order to improvement of treatment facilities and to 
be able to have knowledge transfer between the centres similar with the UK’s audit 
networking systems [31];  
(vi) In vivo dosimetry should be promoted [33];  
(vii) Independent dosimetry checks in co-operation with peers should be encouraged [34]; 
(viii) Follows the audit systems like UK’s which include the use of intercomparisons 
themselves, implementation of Quality Systems and regular Quality audit via Regional 
Dosimetry audit network [35];  
 (ix) To achieve high accuracy of delivery dose to radiotherapy patient, quality assurance 
programmes consist of radiotherapy facilities, dosimetry and process should be supported, 
strengthened, and promoted;  
 (x) Clinical audit should comprise in the dosimetry checklist in order to fulfil assured clinical 
practice [32];  
 (xi) In order to increase the number of dosimetry audit expertise and well trained medical 
physicist in complex radiotherapy techniques, special clinical training course like 
IMRT/IGRT and dosimetry audit should be organized frequently by authority department. In 
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the course, experts in radiotherapy dosimetry from IAEA, EQUAL and RPC should be 
invited;  
 (xii) Lacking of medical physics staffs can be solved when Malaysian government especially 
Public Service Department of Malaysia, Ministry of Health and universities work together to 
promote the profession of medical physics to university students such as providing a 
scholarship and opportunity to have industrial training (hands-on) in government and private 
hospitals, and SSDL Malaysia Nuclear Agency [34];  
 (xiii) Use polymer gel dosimeter as a mailed phantom in postal intercomparison audit 
programmes such as PRESAGE [36] which is capable to verify dose distribution in 3 
dimensions for advanced radiotherapy techniques and also can be cost effectives;  
 (xiv) Development of mailed anthropomorphic phantom or more tissue equivalent, 3 
Dimensional relative and absolute dosimetry for clinical trial and advanced techniques audit 
programmes should be encouraged and promoted. 
7. A Malaysian SSDL participation in the IAEA/WHO TLD Postal Dose Quality Audit 
Service during years of 2011 to 2015 
During the years of 2009 to 2015, a total of 8 intercomparison exercises were carried out by 
Malaysian SSDL in the IAEA/WHO TLD Postal Dose Quality Audit Service. Results of the 
calculated percentage deviations between the SSDL and the IAEA results for TLD 
measurements with both 
60
Co (1.25 MeV) and Linac (6 MV and 10 MV photon beams) are 
shown in Table 1. As expected, all of them yield deviations within the IAEA limit of +3.5%. 
The mean of the distribution is -0.50% and the standard deviation is 0.95%. The deviations 
were varies between a minimum percentage relative deviation of -2.5% and a maximum of 
0.6%. 
Table 1: Results of TLD measurements for Co-60 and high energy photons in the 
IAEA/WHO TLD Postal Dose Quality Audit for Malaysian SSDL.    
  
Radiation 
quality 
Year of 
participation 
SSDL stated 
dose (Gy) 
IAEA mean 
dose (Gy) 

a
 Ratio
b
 
1.25 MeV 
60
Co 2009 2.05 2.05 -0.2 1.00 
  2010 2.06 2.12 -2.5 1.03 
  2014 2.00 2.01 -0.4 1.00 
6 MV X-rays 2011 2.02 2.01 0.6 0.99 
  2013 2.01 2.02 -0.4 1.00 
 2016 2.00 2.00 0.0 1.00 
10 MV X-rays 2012 2.02 2.02 0.0 1.00 
  2015 2.03 2.05 -1.2 1.01 
a
Percentage deviation relative to IAEA measured dose = 100 x (User stated dose - IAEA 
mean dose)/IAEA mean dose  
b
Ratio = IAEA mean dose / User stated dose  
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8. Particicipating Malaysian radiotherapy centres and mailed Ge-doped optical fibres 
dosimetry audit 
 
The aim of the present investigation, using high energy photon beams, is to undertake a pilot 
study aimed at establishing the potential of a mailed commercial Ge-doped optical fibre TL-
system in measuring beam output under reference conditions. The silica-glass optical fibre used 
is single-mode INOCORP (Canada) Ge-doped optical fibre, core diameter 9 μm and cladding 
diameter 116 ± 0.1 μm. The preliminary Ge-doped optical fibre irradiations were performed 
using the Varian linear accelerator located at Royal Surrey Country Hospital (RSCH) [37]. The 
audit was carried out for eight Malaysian radiotherapy centres located at seven locations 
throughout the country, covering Peninsular Malaysia and one location in Malaysian Borneo, 
with a total of eight beam calibrations being checked. Three of the participating centres were 
from general hospitals, while the other five were private medical centres. The most commonly 
used dosimetry protocol in Malaysia to determine absorbed dose to water is the IAEA TRS 398 
(IAEA 2000) [38]. Seven out of the eight participating radiotherapy centres in this audit study 
have already participated in LiF TLD postal dose audit programmes organized by various 
international agencies such as the IAEA, ESTRO and the Forum for Nuclear Cooperation in Asia 
(FNCA) Radiation Oncology project. Capsules were mailed to these centres for irradiation to an 
absorbed dose to water of 2 Gy at 10 cm depth under reference conditions. To ensure a 
standardized irradiation procedure, four Ge-doped optical fibre capsules, a Ge-doped optical 
fibre holder (Figure 2a and b), a radiotherapy centre specific details sheet, a technical instruction 
sheet and a dose data report sheet were sent to each radiotherapy centre. In the described 
methodology three of the Ge-doped fibre capsules were requested to be irradiated while the 
fourth capsule was asked to be treated as the control capsule, used to record environmental 
influences during transportation and storage. Using the returned fibres, TL results were analysed 
according to practices described by the IAEA (2000) [38] and from this, a report of the variation 
from the standard 2 Gy dose was constructed for each of the participant centres. 
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Figure 2 a) Ge-doped optical fibres holder and constituent support parts; b) Schematic of 
assemble holder with the Ge-doped fibres capsule for Ge-doped irradiation. 
8.1 Reporting the audit results 
According to (ISO, 1992) the percentage relative deviation between the obtained and quoted dose 
is defined as: 
                                        
fibres
fibresingparticipat
D
DD
D

 %100                                                                 (1)                                  
 
where absorbed dose equation ( fibresD and ingparticipatD ) were developed by Mohd Noor et al. 
(2014) [37] was employed. In this study, an acceptance limit of ±5% (0.95≤ 








tparticipan
fibres
D
D  ≥1.05) has 
been set for this deviation, as previously used by the ESTRO quality assurance network (EQUAL) 
and the IAEA TLD postal programme. Deviation of more than ±5% and less than ±10% (0.90≤ 








tparticipan
fibres
D
D  ≥0.95) or (1.05≤ 








tparticipan
fibres
D
D  ≥1.10) are considered minor and deviations exceeding ±10% 
(








tparticipan
fibres
D
D ≤ 0.90 or 








tparticipan
fibres
D
D  ≥1.10) are regarded as major (IAEA, 2000) [38].  
 
Full details of the audit results are mailed to participating centres if the deviation is within the 
acceptance limit. However, if there is a deviation outside tolerance, the participating centre is 
informed that there has been a deviation but are not informed of its magnitude or deviation and 
will be asked to repeat the measurement again as soon as possible. In the case of a major 
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deviation following the repeat measurement, the Malaysian SSDL is informed and a detailed on-
site audit visit carried out by SSDL Malaysia may then be required.  
 
8.1.1 Uncertainty of deviation in the ratio 




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


tparticipan
fibres
D
D  
Generally all the audit results are reported as the ratio of the obtained dose as calibrated at 
reference centres, fibresD  , to the dose quoted by the participating centres, tparticipanD . To calculate 
the uncertainty in this ratio, the following equation was applied: 
                                   








tparticipan
fibres
D
D
u =
I
DuDu tparticipanfibresc
22 )()( 
                             (2) 
where )( fibresc Du  is the uncertainty in the dose obtained from the fibre measurement published 
by Mohd Noor et al. (2014) [37], )( tparticipanDu is the uncertainty in the dose quoted by the 
participating centres according to the IAEA Code of Practice TRS 398 (IAEA, 2000) [38]. The 
number of fibres used to determine the ratio is represented by I.   
8.2 Malaysian mailed Ge-doped optical fibres postal dose audit results 
Of the centres participating in previous audits, all the results were found to produce values in the 
range less than ± 3 %, noting the acceptance limit to be ± 5 %. The present postal dose audit, 
based on the use of Ge-doped optical fibre, is the first of its kind to be carried out. The results of 
the audit are shown in figure 3a. Each data point corresponds to the average from three capsules 
of Ge-doped fibre. The histogram corresponds to ratios of the obtained dose calculated (D(fibres)) 
relative to the dose quoted by each of the Malaysian radiotherapy centres (D(participant)). The mean 
ratio of measured to quoted dose was 0.99 with a standard deviation of 3 %. The ratio of the 
results varies between a minimum dose of 0.92 and a maximum of 1.03. One out of the eight 
beams checked was shown to produce a deviation of more than ± 5 % but less than ± 10 %. The 
particular centre has never previously participated in any audit programme involving mailed 
TLDs. Investigation showed that as a result of misinterpretation of the instructions on how to 
carry out the irradiation, the Ge-doped fibres were subjected to an incorrect dose. The particular 
centre was informed about the issue and asked to perform a second measurement. Figure 3b 
shows the distribution of results following the repeat measurement.  The mean distribution was 
1.00 with a standard deviation of 1.3 %. The maximum and minimum result of the ratio is 1.03 
and 0.99 respectively, all within the acceptance limit (± 5 %). Izewska and Andreo (2000) stated 
that “only 65 % of the hospitals that received TLD for the first time produced results within the 
acceptance limit (± 5 %), while 81 % of the institutions participating regularly in the audits have 
produced results within the (± 5 %) limits”. Of importance is that such efforts, viz regular 
(periodic) participation in external audits, can help to maintain accurate dosimetry, and 
especially so in developing countries where such support can be invaluable (Rassiah 2004) [21]. 
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Figure 3a Histogram of the relative TL responses (D(fibres)/D(participant)) of the eight participating 
Malaysian radiotherapy centres. The distribution of the mean is 0.99 with 0.03 standard 
deviation. Distribution of the mean is 0.99 with 0.03 standard deviation. Figure 3b Histogram 
of the relative TL responses (D(fibres)/D(participant)) of the eight radiotherapy centres following 
one repeat irradiation. Note that D(fibres) is the dose obtained at the RSCH relative to the dose 
quoted by the Malaysian radiotherapy centres, D(participant)). The distribution of the mean is 
1.00 with 0.01 standard deviation. 
8.2.1 Uncertainty in the ratio of  
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Uncertainty in the ratio of 


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



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fibres
D
D
 has been calculated in accord with equation 2. All ion 
chambers used in Malaysia are calibrated at the Malaysian SSDL; the Malaysian SSDL factors 
are traceable to the IAEA and sequentially traceable to the Bureau International des Poids et 
Measures (BIPM). The uncertainty attributed to the SSDL is 1.2% at a 95% confidence (two 
standard deviation) determined by the IAEA, (2000) [38]. Using )( tparticipanDu  as 1.20% and 
)( fibresc Du as 2.11, 







tparticipan
fibres
D
D
u  provides an uncertainty of 1.40%. 
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9. Conclusion 
The audit carried out to-date indicates that one out of eight centres has shown a minor deviation. 
Unfamiliarity of the physicist of the particular centre with the irradiation procedures was found 
to be a possible cause of the deviation. The mean ratio of measured to quoted dose was found to 
be 0.99 with standard deviation 3%, prior to repeated measurement. Following repeated 
measurement of the audit, the mean distribution was found to be 1.00 with standard deviation 
1.3%. Using equation 2, uncertainty in the ratio of dose measured by fibres to the dose stated by 
the participants is found to be 1.4%. In conclusion, with repeat intercomparison programmes, 
the deviations have also been shown to decrease as has improved consistency of dosimetry. 9 
µm diameter core Ge-doped fibres represent a viable system for use in mailed audit radiotherapy 
programmes. 
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